Literature DB >> 27645385

Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.

Etsuko Sugawara1, Seiji Kojima1, Hiroshi Nikaido2.   

Abstract

Klebsiella pneumoniae, one of the most important nosocomial pathogens, is becoming a major problem in health care because of its resistance to multiple antibiotics, including cephalosporins of the latest generation and, more recently, even carbapenems. This is largely due to the spread of plasmid-encoded extended-spectrum β-lactamases. However, antimicrobial agents must first penetrate the outer membrane barrier in order to reach their targets, and hydrophilic and charged β-lactams presumably diffuse through the porin channels. Unfortunately, the properties of K. pneumoniae porin channels are largely unknown. In this study, we made clean deletions of K. pneumoniae porin genes ompK35 and ompK36 and examined the antibiotic susceptibilities and diffusion rates of β-lactams. The results showed that OmpK35 and OmpK36 produced larger more permeable channels than their Escherichia coli homologs OmpF and OmpC; OmpK35 especially produced a diffusion channel of remarkably high permeability toward lipophilic (benzylpenicillin) and large (cefepime) compounds. These results were also confirmed by expressing various porins in an E. coli strain lacking major porins and the major multidrug efflux pump AcrAB. Our data explain why the development of drug resistance in K. pneumoniae is so often accompanied by the mutational loss of its porins, especially OmpK35, in addition to the various plasmid-carried genes of antibiotic resistance, because even hydrolysis by β-lactamases becomes inefficient in producing high levels of resistance if the bacterium continues to allow a rapid influx of β-lactams through its wide porin channels. IMPORTANCE: In Gram-negative bacteria, drugs must first enter the outer membrane, usually through porin channels. Thus, the quantitative examination of influx rates is essential for the assessment of resistance mechanisms, yet no such studies exist for a very important nosocomial pathogen, Klebsiella pneumoniae We found that the larger channel porin of this organism, OmpK35, produces a significantly larger channel than its Escherichia coli homolog, OmpF. This makes unmodified K. pneumoniae strains more susceptible to relatively large antibiotics, such as the third- and fourth-generation cephalosporins. Also, even the acquisition of powerful β-lactamases is not likely to make them fully resistant in the presence of such an effective influx process, explaining why so many clinical isolates of this organism lack porins.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27645385      PMCID: PMC5105900          DOI: 10.1128/JB.00590-16

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  59 in total

1.  Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams.

Authors:  A Mazzariol; G Cornaglia; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 3.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

Authors:  B Pangon; C Bizet; A Buré; F Pichon; A Philippon; B Regnier; L Gutmann
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

5.  High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.

Authors:  L B Rice; L L Carias; A M Hujer; M Bonafede; R Hutton; C Hoyen; R A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

6.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

7.  Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

Authors:  Michel Doumith; Matthew J Ellington; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2009-02-20       Impact factor: 5.790

8.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

9.  Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.

Authors:  E C Nelson; Heidi Segal; B Gay Elisha
Journal:  J Antimicrob Chemother       Date:  2003-11-12       Impact factor: 5.790

10.  Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.

Authors:  C Ardanuy; J Liñares; M A Domínguez; S Hernández-Allés; V J Benedí; L Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  28 in total

1.  Outer Membrane Permeability of Cyanobacterium Synechocystis sp. Strain PCC 6803: Studies of Passive Diffusion of Small Organic Nutrients Reveal the Absence of Classical Porins and Intrinsically Low Permeability.

Authors:  Hikaru Kowata; Saeko Tochigi; Hideyuki Takahashi; Seiji Kojima
Journal:  J Bacteriol       Date:  2017-09-05       Impact factor: 3.490

Review 2.  Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria.

Authors:  Julia Vergalli; Igor V Bodrenko; Muriel Masi; Lucile Moynié; Silvia Acosta-Gutiérrez; James H Naismith; Anne Davin-Regli; Matteo Ceccarelli; Bert van den Berg; Mathias Winterhalter; Jean-Marie Pagès
Journal:  Nat Rev Microbiol       Date:  2019-12-02       Impact factor: 60.633

3.  An outbreak of ertapenem-resistant, carbapenemase-negative and porin-deficient ESBL-producing Klebsiella pneumoniae complex.

Authors:  Mihaela Matovina; Maja Abram; Davorka Repac-Antić; Samira Knežević; Marina Bubonja-Šonje
Journal:  Germs       Date:  2021-06-02

Review 4.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

5.  Mutation of PA4292 in Pseudomonas aeruginosa Increases β-Lactam Resistance through Upregulating Pyocyanin Production.

Authors:  Xinrui Zhao; Yongxin Jin; Fang Bai; Zhihui Cheng; Weihui Wu; Xiaolei Pan
Journal:  Antimicrob Agents Chemother       Date:  2022-06-13       Impact factor: 5.938

6.  High Osmotic Stress Increases OmpK36 Expression through the Regulation of KbvR to Decrease the Antimicrobial Resistance of Klebsiella pneumoniae.

Authors:  Meng Wang; Yujiao Tian; Li Xu; Fusheng Zhang; Huigai Lu; Moran Li; Bei Li
Journal:  Microbiol Spectr       Date:  2022-06-06

7.  Molecular Characterization of Klebsiella pneumoniae Clinical Isolates with Elevated Resistance to Carbapenems.

Authors:  Rasha Barwa; Mona Shaaban
Journal:  Open Microbiol J       Date:  2017-07-31

Review 8.  Exploring bacterial outer membrane barrier to combat bad bugs.

Authors:  Ishan Ghai; Shashank Ghai
Journal:  Infect Drug Resist       Date:  2017-08-30       Impact factor: 4.003

9.  Extensively Drug-Resistant Klebsiella pneumoniae Causing Nosocomial Bloodstream Infections in China: Molecular Investigation of Antibiotic Resistance Determinants, Informing Therapy, and Clinical Outcomes.

Authors:  Wenzi Bi; Haiyang Liu; Rhys A Dunstan; Bin Li; Von Vergel L Torres; Jianming Cao; Lijiang Chen; Jonathan J Wilksch; Richard A Strugnell; Trevor Lithgow; Tieli Zhou
Journal:  Front Microbiol       Date:  2017-06-30       Impact factor: 5.640

10.  bla OXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands.

Authors:  Antoni P A Hendrickx; Fabian Landman; Angela de Haan; Sandra Witteveen; Marga G van Santen-Verheuvel; Leo M Schouls
Journal:  Microb Genom       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.